Biotech companies directory 2026

    Biotech Companies in Qatar

    Qatar’s biotechnology story is a national sequencing programme, a children’s research hospital and a science park, not a cluster of listed drug-discovery companies: Qatar Genome and Qatar Biobank sit inside Qatar Foundation, Sidra Medicine runs the paediatric and women’s research wards, and Hamad Bin Khalifa University’s Qatar Biomedical Research Institute does the wet-lab work that foreign partners actually visit.

    The Ministry of Public Health licences clinical research and advanced therapies; Hamad Medical Corporation remains the adult tertiary system that would have to adopt any locally developed protocol. Weill Cornell Medicine-Qatar and Qatar University supply investigators and teaching laboratories. Qatar Science & Technology Park in Education City leases space to instrument, reagent and digital-health tenants rather than to a Genentech-style campus. There is no PIF-style biomanufacturing champion and no insulin crystal hall on the peninsula. Partnering conversations therefore pass through Foundation programmes, Sidra and Hamad research offices, and the ministry file — in that order — before anyone should ask who will fill a vial. BioNixus sets the names out by function so a licensing or trial-feasibility brief starts at the right door and does not treat Doha as a Riyadh localisation play.

    Updated September 2026 · Ministry of Public Health (MoPH) — clinical research and healthcare-facility licensing as of September 2026 · 16 named accounts

    Request a proposal for QatarBrowse the 16 companies

    1

    National genome programme (Qatar Genome) sequenced against a Qatari reference panel

    Education City

    Campus that hosts QBRI, Weill Cornell Medicine-Qatar, QSTP and Qatar Foundation research arms

    Sidra

    Women’s and children’s academic medical centre that runs the highest-profile paediatric research wards

    MoPH

    Ministry that licences interventional research and advanced-therapy use

    Named accounts

    Top biotechnology companies in Qatar

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Ministry of Public Health (MoPH) — clinical research and healthcare-facility licensing (as of 2026-09-05).
    #CompanyHQ
    01Qatar Genome ProgrammeDoha
    02Qatar BiobankDoha
    03Qatar Biomedical Research Institute (QBRI) — HBKUDoha
    04Sidra MedicineDoha
    05Hamad Medical Corporation — Medical Research CenterDoha
    06Weill Cornell Medicine-QatarDoha
    07Qatar University — Biomedical Research CenterDoha
    08Qatar Science & Technology Park (QSTP)Doha
    09Hamad Bin Khalifa University (HBKU)Doha
    10Qatar FoundationDoha
    11Aspetar Orthopaedic and Sports Medicine Hospital — research unitDoha
    12Primary Health Care Corporation (PHCC) — researchDoha
    13Ministry of Public Health (MoPH)Doha
    14Qatar Research, Development and Innovation Council (QRDI)Doha
    15Sedeer MedicalDoha
    16Naufar — research and clinical programmesDoha

    Primary research

    These are the biotech and innovation accounts we track in Qatar

    Partnering, licensing or launching a biologic in Qatar? BioNixus runs KOL, payer and regulator interviews plus hospital-level demand sizing. Proposal within 48 hours.

    Planning research in Qatar?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in Qatar (2026)

    How the market is structured

    How Foundation capital, Sidra wards and MoPH files shape Qatari biotechnology

    Money in Qatari life science is public and programme-shaped. Qatar Foundation funds Qatar Genome, Qatar Biobank and HBKU’s biomedical institute; those programmes then invite foreign sequencing, bioinformatics and rare-disease partners to work on a Qatari cohort rather than to build a private pipeline. Sidra Medicine is the hospital that can actually enrol children and women on industry or investigator-initiated protocols, with Hamad Medical Corporation the adult counterpart. Weill Cornell Medicine-Qatar sits on the same Education City campus and supplies clinician-scientists who already know US IRB language. QSTP is a free-zone address for instrument houses, digital-health start-ups and the occasional reagent distributor; it is not a GMP biologics park. The Ministry of Public Health, not a medicines agency cloned on SFDA lines, is the file for interventional drug studies and for any cell or gene therapy that would be used in a Hamad or Sidra ward. There is no NUPCO-style national offtake that can localise a vial plant, and no listed biosimilar manufacturer. A team that arrives with a fill-finish joint-venture slide will waste a quarter; a team that arrives with a genomics, rare-disease or paediatric-site slide will find a conversation. Demand for originator biologics still runs through Hamad procurement and through the commercial medical writers mapped on the Qatar health-insurers directory — separate from this research-infrastructure map.

    Local

    Foundation programmes, HBKU/QBRI and Qatar University laboratories — the Qatari public research layer that owns cohorts, samples and graduate benches.

    Multinational

    Weill Cornell Medicine-Qatar and the foreign sequencing or rare-disease partners invited onto the genome and Sidra files; they do not operate vial plants here.

    • Weill Cornell Medicine-Qatar

    Regional

    Incoming Gulf or Levant manufacturers are rare on this map; Qatar buys originator biologics and hosts research, it does not yet export biosimilars.

    Incubators, CDMOs & partners

    MoPH, QSTP tenancy, research-tools distributors such as Sedeer, and the Hamad/Sidra/PHCC site offices that decide whether a protocol can actually enrol.

    • Qatar Genome Programme
    • Qatar Biobank
    • Qatar Biomedical Research Institute (QBRI) — HBKU
    • Sidra Medicine
    • Hamad Medical Corporation — Medical Research Center
    • Qatar University — Biomedical Research Center
    • Qatar Science & Technology Park (QSTP)
    • Hamad Bin Khalifa University (HBKU)
    • Qatar Foundation
    • Aspetar Orthopaedic and Sports Medicine Hospital — research unit
    • Primary Health Care Corporation (PHCC) — research
    • Ministry of Public Health (MoPH)
    • Qatar Research, Development and Innovation Council (QRDI)
    • Sedeer Medical
    • Naufar — research and clinical programmes

    What is moving

    What is moving biotechnology in Qatar

    A sequenced national cohort as the asset

    Qatar Genome plus Qatar Biobank is what foreign precision-medicine teams come for; manufacturing localisation is a Saudi conversation, not a Doha one.

    Sidra as the paediatric research door

    Women’s and children’s protocols that cannot enrol at Gulf adult hospitals still land at Sidra, which is why feasibility that only names Hamad will miss first patient.

    Education City as a single campus

    QBRI, Weill Cornell, QSTP and Foundation legal sit within a few minutes of each other, so a well-run partnering week can clear academic, hospital and park doors in one trip.

    No local fill-finish champion

    Absence of a Lifera- or Julphar-style plant keeps Qatar a research and adoption market; originator biologics still enter through Hamad procurement and commercial medical cards.

    BioNixus fieldwork

    How BioNixus studies biotechnology companies in Qatar

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Qatar:
    • Sidra and Hamad research-office interviews on paediatric versus adult enrolment, IRB clocks and industry-contract language.
    • Mapping of Qatar Genome and Qatar Biobank access paths with Foundation and QRDI counterparts.
    • QSTP tenant walkthroughs that separate instrument and digital-health occupancy from any GMP biologics claim.
    • MoPH file timing for interventional protocols that already have Sidra or Hamad ethics letters.

    Biotech market research in Qatar

    Questions

    Frequently Asked Questions

    Does Qatar manufacture biologics or vaccines at scale?

    Not as a commercial industrial base. The country’s biotechnology weight is genomics, biobanking, academic laboratories and hospital research sites. Fill-finish and insulin crystals sit in other Gulf states.

    Who should a rare-disease or genomics partner call first?

    Qatar Genome and Qatar Biobank through Qatar Foundation, then Sidra or Hamad depending on paediatric versus adult care, then MoPH for any interventional file.

    Is QSTP a manufacturing free zone for biologics?

    It is a science-park and free-zone address for applied research, instruments and digital health. Do not brief it as a CDMO campus.

    How does this directory differ from the Qatar health-insurers page?

    This list is research infrastructure and licences. Commercial medical writers, Hamad citizen provision and QCB insurance licences sit on the insurers directory.

    What fieldwork does BioNixus run on Qatari biotechnology organisations?

    Investigator and research-office interviews at Sidra and Hamad, mapping of genome-programme access paths, and protocol-start-up timing with MoPH and hospital IRBs — not plant-capability audits.

    Does table order rank Qatari biotech companies?

    No. Names appear because they recur in BioNixus Doha feasibility and partnering work. The sort is by role: programme, hospital, university, park, ministry, tools distributor.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Qatar. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Ministry of Public Health (MoPH) — clinical research and healthcare-facility licensing, consulted 2026-09-05. Company classification (Local / MNC / Regional / incubators, cdmos & partners) reflects ownership and role in Qatar, not size.

    • Qatar Genome Programme and Qatar Biobank public programme descriptions, Qatar Foundation
    • Sidra Medicine and Hamad Medical Corporation research-office materials
    • HBKU Qatar Biomedical Research Institute and Qatar Science & Technology Park tenancy information
    • BioNixus Qatar clinical-research and life-science partnering fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need biotech and biologics market data in Qatar?

    Payer appetite, biosimilar uptake, KOL sentiment and tender exposure — primary research, not desk estimates.

    Planning research in Qatar?

    Primary research, market access & HEOR. Proposals within 48 hours.